FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063956314> ?p ?o ?g. }

• W2063956314 endingPage "199" @default.
• W2063956314 startingPage "195" @default.
• W2063956314 abstract "Topical microbicides for use by women to prevent the transmission of human immunodeficiency virus (HIV) and other sexually transmitted infections are urgently required. Dendrimers are highly branched nanoparticles being developed as microbicides. SPL7013 is a dendrimer with broad-spectrum activity against HIV type I (HIV-1) and -2 (HIV-2), herpes simplex viruses type-1 (HSV-1) and -2 (HSV-2) and human papillomavirus. SPL7013 [3% (w/w)] has been formulated in a mucoadhesive carbopol gel (VivaGel®) for use as a topical microbicide. Previous studies showed that SPL7013 has similar potency against CXCR4-(X4) and CCR5-using (R5) strains of HIV-1 and that it blocks viral entry. However, the ability of SPL7013 to directly inactivate HIV-1 is unknown. We examined whether SPL7013 demonstrates virucidal activity against X4 (NL4.3, MBC200, CMU02 clade EA and 92UG046 clade D), R5 (Ba-L, NB25 and 92RW016 clade A) and dual-tropic (R5X4; MACS1-spln) HIV-1 using a modified HLA-DR viral capture method and by polyethylene glycol precipitation. Evaluation of virion integrity was determined by ultracentrifugation through a sucrose cushion and detection of viral proteins by Western blot analysis. SPL7013 demonstrated potent virucidal activity against X4 and R5X4 strains, although virucidal activity was less potent for the 92UG046 X4 clade D isolate. Where potent virucidal activity was observed, the 50% virucidal concentrations were similar to the 50% effective concentrations previously reported in drug susceptibility assays, indicating that the main mode of action of SPL7013 is by direct viral inactivation for these strains. In contrast, SPL7013 lacked potent virucidal activity against R5 HIV-1 strains. Evaluation of the virucidal mechanism showed that SPL7013-treated NL4.3, 92UG046 and MACS1-spln virions were intact with no significant decrease in gp120 surface protein with respect to p24 capsid content compared to the corresponding untreated virus. These studies demonstrate that SPL7013 is virucidal against HIV-1 strains that utilize the CXCR4 coreceptor but not viruses tested in this study that solely use CCR5 by a mechanism that is distinct from virion disruption or loss of gp120. In addition, the mode of action by which SPL7013 prevents infection of cells with X4 and R5X4 strains is likely to differ from R5 strains of HIV-1." @default.
• W2063956314 created "2016-06-24" @default.
• W2063956314 creator A5002993648 @default.
• W2063956314 creator A5018910367 @default.
• W2063956314 creator A5032456293 @default.
• W2063956314 creator A5036388659 @default.
• W2063956314 creator A5040751670 @default.
• W2063956314 creator A5045316156 @default.
• W2063956314 creator A5046491505 @default.
• W2063956314 creator A5055118021 @default.
• W2063956314 creator A5055513726 @default.
• W2063956314 creator A5072751680 @default.
• W2063956314 creator A5091161981 @default.
• W2063956314 creator A5091208578 @default.
• W2063956314 date "2011-06-01" @default.
• W2063956314 modified "2023-09-26" @default.
• W2063956314 title "Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1" @default.
• W2063956314 cites W1505727107 @default.
• W2063956314 cites W1699035887 @default.
• W2063956314 cites W1832836414 @default.
• W2063956314 cites W1970326640 @default.
• W2063956314 cites W1994478201 @default.
• W2063956314 cites W2015727594 @default.
• W2063956314 cites W2020394552 @default.
• W2063956314 cites W2023610134 @default.
• W2063956314 cites W2036479803 @default.
• W2063956314 cites W2050801792 @default.
• W2063956314 cites W2054839188 @default.
• W2063956314 cites W2058062806 @default.
• W2063956314 cites W2071973257 @default.
• W2063956314 cites W2078135849 @default.
• W2063956314 cites W2096077458 @default.
• W2063956314 cites W2097305591 @default.
• W2063956314 cites W2111621727 @default.
• W2063956314 cites W2116590547 @default.
• W2063956314 cites W2118730972 @default.
• W2063956314 cites W2120078856 @default.
• W2063956314 cites W2135858941 @default.
• W2063956314 cites W2146634980 @default.
• W2063956314 cites W2154004911 @default.
• W2063956314 cites W2154142064 @default.
• W2063956314 cites W2154513072 @default.
• W2063956314 cites W2166916078 @default.
• W2063956314 cites W2169923259 @default.
• W2063956314 cites W2138477719 @default.
• W2063956314 doi "https://doi.org/10.1016/j.antiviral.2011.03.186" @default.
• W2063956314 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3115201" @default.
• W2063956314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21459115" @default.
• W2063956314 hasPublicationYear "2011" @default.
• W2063956314 type Work @default.
• W2063956314 sameAs 2063956314 @default.
• W2063956314 citedByCount "86" @default.
• W2063956314 countsByYear W20639563142012 @default.
• W2063956314 countsByYear W20639563142013 @default.
• W2063956314 countsByYear W20639563142014 @default.
• W2063956314 countsByYear W20639563142015 @default.
• W2063956314 countsByYear W20639563142016 @default.
• W2063956314 countsByYear W20639563142017 @default.
• W2063956314 countsByYear W20639563142018 @default.
• W2063956314 countsByYear W20639563142019 @default.
• W2063956314 countsByYear W20639563142020 @default.
• W2063956314 countsByYear W20639563142021 @default.
• W2063956314 countsByYear W20639563142022 @default.
• W2063956314 countsByYear W20639563142023 @default.
• W2063956314 crossrefType "journal-article" @default.
• W2063956314 hasAuthorship W2063956314A5002993648 @default.
• W2063956314 hasAuthorship W2063956314A5018910367 @default.
• W2063956314 hasAuthorship W2063956314A5032456293 @default.
• W2063956314 hasAuthorship W2063956314A5036388659 @default.
• W2063956314 hasAuthorship W2063956314A5040751670 @default.
• W2063956314 hasAuthorship W2063956314A5045316156 @default.
• W2063956314 hasAuthorship W2063956314A5046491505 @default.
• W2063956314 hasAuthorship W2063956314A5055118021 @default.
• W2063956314 hasAuthorship W2063956314A5055513726 @default.
• W2063956314 hasAuthorship W2063956314A5072751680 @default.
• W2063956314 hasAuthorship W2063956314A5091161981 @default.
• W2063956314 hasAuthorship W2063956314A5091208578 @default.
• W2063956314 hasBestOaLocation W20639563142 @default.
• W2063956314 hasConcept C117214928 @default.
• W2063956314 hasConcept C140704245 @default.
• W2063956314 hasConcept C159047783 @default.
• W2063956314 hasConcept C185592680 @default.
• W2063956314 hasConcept C197746943 @default.
• W2063956314 hasConcept C202751555 @default.
• W2063956314 hasConcept C2522874641 @default.
• W2063956314 hasConcept C2776997796 @default.
• W2063956314 hasConcept C2908647359 @default.
• W2063956314 hasConcept C2986740045 @default.
• W2063956314 hasConcept C3013748606 @default.
• W2063956314 hasConcept C55493867 @default.
• W2063956314 hasConcept C55637122 @default.
• W2063956314 hasConcept C57992300 @default.
• W2063956314 hasConcept C58475186 @default.
• W2063956314 hasConcept C71924100 @default.
• W2063956314 hasConcept C86803240 @default.
• W2063956314 hasConcept C89423630 @default.
• W2063956314 hasConcept C97380033 @default.
• W2063956314 hasConcept C99454951 @default.

• next